BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen T, Dai X, Dai J, Ding C, Zhang Z, Lin Z, Hu J, Lu M, Wang Z, Qi Y, Zhang L, Pan R, Zhao Z, Lu L, Liao W, Lu X. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death Dis. 2020;11:822. [PMID: 33009373 DOI: 10.1038/s41419-020-03030-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Abdel-hamid NM, Abass SA, Eldomany RA, Abdel-kareem MA, Zakaria S. Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats. Life Sciences 2022;294:120369. [DOI: 10.1016/j.lfs.2022.120369] [Reference Citation Analysis]
2 Sun L, Cen W, Tang W, Deng L, Wang F, Ji X, Yang J, Zhang R, Zhang X, Du Z, Mei J. Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy. Disease Markers 2022;2022:1-9. [DOI: 10.1155/2022/7640560] [Reference Citation Analysis]
3 Lin Z, Miao D, Xu Q, Wang X, Yu F. A novel focal adhesion related gene signature for prognostic prediction in hepatocellular carcinoma. Aging (Albany NY) 2021;13:10724-48. [PMID: 33850056 DOI: 10.18632/aging.202871] [Reference Citation Analysis]
4 Zhang W, Pan R, Lu M, Zhang Q, Lin Z, Qin Y, Wang Z, Gong S, Lin H, Chong S, Lu L, Liao W, Lu X. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway. Oncogene 2021;40:6369-80. [PMID: 34588619 DOI: 10.1038/s41388-021-02029-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zhang L, Liu Y, Tao H, Zhu H, Pan Y, Li P, Liang H, Zhang B, Song J. Circular RNA circUBE2J2 acts as the sponge of microRNA-370-5P to suppress hepatocellular carcinoma progression. Cell Death Dis 2021;12:985. [PMID: 34686662 DOI: 10.1038/s41419-021-04269-4] [Reference Citation Analysis]
6 Xiao H, Ye X, Vishwakarma V, Preet R, Dixon DA. CRC-derived exosomes containing the RNA binding protein HuR promote lung cell proliferation by stabilizing c-Myc mRNA. Cancer Biol Ther 2022;23:139-49. [PMID: 35130122 DOI: 10.1080/15384047.2022.2034455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li C, Salmen SH, Awad Alahmadi T, Priya Veeraraghavan V, Krishna Mohan S, Natarajan N, Subramanian S. Anticancer effect of Selenium/Chitosan/Polyethylene glycol/Allyl isothiocyanate nanocomposites against diethylnitrosamine-induced liver cancer in rats. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.02.012] [Reference Citation Analysis]
8 Charneau J, Suzuki T, Shimomura M, Fujinami N, Nakatsura T. Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances. J Hepatocell Carcinoma 2021;8:1035-54. [PMID: 34513746 DOI: 10.2147/JHC.S291558] [Reference Citation Analysis]
9 Li S, Li Y, Sun H, Jiang Y, Pan K, Su Y, Bu N. Mulberry fruit polysaccharides alleviate diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis in vivo: the roles of cell apoptosis and inflammation. Bioengineered 2021;12:11599-611. [PMID: 34866538 DOI: 10.1080/21655979.2021.1993716] [Reference Citation Analysis]
10 Udho EB, Huebner SM, Albrecht DM, Matkowskyj KA, Clipson L, Hedican CA, Koth R, Snow SM, Eberhardt EL, Miller D, Van Doorn R, Gjyzeli G, Spengler EK, Storts DR, Thamm DH, Edmondson EF, Weil MM, Halberg RB, Bacher JW. Tumor aggressiveness is independent of radiation quality in murine hepatocellular carcinoma and mammary tumor models. Int J Radiat Biol 2021;97:1140-51. [PMID: 33720813 DOI: 10.1080/09553002.2021.1900946] [Reference Citation Analysis]
11 Niu M, Yi M, Li N, Wu K, Wu K. Advances of Targeted Therapy for Hepatocellular Carcinoma. Front Oncol 2021;11:719896. [PMID: 34381735 DOI: 10.3389/fonc.2021.719896] [Reference Citation Analysis]
12 He JJ, Shang L, Yu QW, Jiao N, Qiu S, Zhu WX, Wu DF, Tian YE, Zhang Q. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World J Gastrointest Oncol 2021; 13(7): 716-731 [PMID: 34322200 DOI: 10.4251/wjgo.v13.i7.716] [Reference Citation Analysis]
13 Wang J, Wang C, Yang L, Li K. Identification of the critical genes and miRNAs in hepatocellular carcinoma by integrated bioinformatics analysis. Med Oncol 2022;39:21. [PMID: 34982264 DOI: 10.1007/s12032-021-01622-7] [Reference Citation Analysis]
14 Ridder DA, Weinmann A, Schindeldecker M, Urbansky LL, Berndt K, Gerber TS, Lang H, Lotz J, Lackner KJ, Roth W, Straub BK. Comprehensive clinicopathologic study of alpha fetoprotein-expression in a large cohort of patients with hepatocellular carcinoma. Int J Cancer 2021. [PMID: 34894400 DOI: 10.1002/ijc.33898] [Reference Citation Analysis]
15 Ye X, Fu Q, Xiao H. The Role of RNA-Binding Protein HuR in Lung Cancer by RNA Sequencing Analysis. Front Genet 2022;13:813268. [PMID: 35450220 DOI: 10.3389/fgene.2022.813268] [Reference Citation Analysis]
16 Xu J, Lin H, Wu G, Zhu M, Li M. IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma. Front Oncol 2021;11:760971. [PMID: 34976809 DOI: 10.3389/fonc.2021.760971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
17 Carr BI, Guerra V, Donghia R, Farinati F, Giannini EG, Muratori L, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Celsa C, Campani C, Mega A, Guarino M, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Biasini E, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Brunetto MR, Trevisani F. Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs. Cancers (Basel) 2021;13:592. [PMID: 33546234 DOI: 10.3390/cancers13040592] [Reference Citation Analysis]
18 He J, Shang L, Yu Q, Jiao N, Qiu S, Zhu W, Wu D, Tian Y, Zhang Q. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. WJGO 2021;13:541-56. [DOI: 10.4251/wjgo.v13.i7.541] [Reference Citation Analysis]
19 Lachiondo-ortega S, Delgado TC, Baños-jaime B, Velázquez-cruz A, Díaz-moreno I, Martínez-chantar ML. Hu Antigen R (HuR) Protein Structure, Function and Regulation in Hepatobiliary Tumors. Cancers 2022;14:2666. [DOI: 10.3390/cancers14112666] [Reference Citation Analysis]
20 Hishida T, Yamamoto M, Hishida-Nozaki Y, Shao C, Huang L, Wang C, Shojima K, Xue Y, Hang Y, Shokhirev M, Memczak S, Sahu SK, Hatanaka F, Ros RR, Maxwell MB, Chavez J, Shao Y, Liao HK, Martinez-Redondo P, Guillen-Guillen I, Hernandez-Benitez R, Esteban CR, Qu J, Holmes MC, Yi F, Hickey RD, Garcia PG, Delicado EN, Castells A, Campistol JM, Yu Y, Hargreaves DC, Asai A, Reddy P, Liu GH, Izpisua Belmonte JC. In vivo partial cellular reprogramming enhances liver plasticity and regeneration. Cell Rep 2022;39:110730. [PMID: 35476977 DOI: 10.1016/j.celrep.2022.110730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Feng L, Wang Y, Wang X, An S, Aizimuaji Z, Tao C, Zhang K, Cheng S, Wu J, Xiao T, Rong W. Integrated analysis of the rhesus monkey liver transcriptome during development and human primary HCC AFP-related gene expression. Mol Ther Nucleic Acids 2021;25:406-15. [PMID: 34484865 DOI: 10.1016/j.omtn.2021.06.004] [Reference Citation Analysis]
22 Hu G, Gao F, Wang G, Fang Y, Guo Y, Zhou J, Gu Y, Zhang C, Gao N, Wen Q, Qiao H. Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker. J Transl Med 2021;19:359. [PMID: 34412629 DOI: 10.1186/s12967-021-03038-3] [Reference Citation Analysis]
23 Zhu H, Zhang H, Pei Y, Liao Z, Liu F, Su C, Liu Y, Dong R, Song J, Zhang X, Fan Y, Liang H, Zhang B, Chen X. Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression.J Exp Clin Cancer Res. 2021;40:57. [PMID: 33541391 DOI: 10.1186/s13046-021-01861-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Chong H, Gong Y, Zhang Y, Dai Y, Sheng R, Zeng M. Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence. Acad Radiol 2022:S1076-6332(22)00254-9. [PMID: 35562264 DOI: 10.1016/j.acra.2022.04.006] [Reference Citation Analysis]
25 Huang SL, Wang YM, Wang QY, Feng GG, Wu FQ, Yang LM, Zhang XH, Xin HW. Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy. Front Genet 2021;12:691391. [PMID: 34306031 DOI: 10.3389/fgene.2021.691391] [Reference Citation Analysis]
26 Wei X, Su R, Yang M, Pan B, Lu J, Lin H, Shu W, Wang R, Xu X. Quantitative proteomic profiling of hepatocellular carcinoma at different serum alpha-fetoprotein level. Translational Oncology 2022;20:101422. [DOI: 10.1016/j.tranon.2022.101422] [Reference Citation Analysis]
27 Wu D, Zhang R, Zhan L. Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile. Clin Res Hepatol Gastroenterol 2021;46:101812. [PMID: 34597849 DOI: 10.1016/j.clinre.2021.101812] [Reference Citation Analysis]